Developing an unparalleled platform integrating proprietary molecular biology technologies with machine learning to maximise the commercial potential of 3D genomics.
History and Mission
Enhanc3D Genomics was spun out from the laboratories of Dr. Stefan Schoenfelder and Professor Peter Fraser, who pioneered research into the dynamic spatial organisation of the genome at the Babraham Institute in Cambridge, UK.
Our mission is to unlock the full potential of the human genome’s 3D organisation for target and biomarker discovery.
Investors
We are backed by Bioqube Ventures, Start Codon, BGF, Parkwalk, and private investors.
